New Antibiotic Hits the Market to Tackle Stubborn UTIs

  • 📰 Gizmodo
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Switzerland Nachrichten Nachrichten

Switzerland Neuesten Nachrichten,Switzerland Schlagzeilen

The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to treat certain UTIs resistant to other drugs.

No doubt about it, UTIs suck. They burn, they itch, they come back just when you think you’re in the clear. But for those dealing with these relentless infections, there’s finally a new line of defense.

Orlynvah is the first drug of its kind. It contains a combination of sulopenem etzadroxil, which belongs to a subclass of antibacterials called penems, and probenecid, a renal tubular transport inhibitor that has been used in the past to boost the duration of antibiotics in our body. Penems arethat has shown great promise in treating a wide variety of commonly resistant germs, but Orlynvah is the first ever oral penem to be approved in the U.S.bacteria.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 556. in CH
 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

Switzerland Neuesten Nachrichten, Switzerland Schlagzeilen